ArticleAnnals of medicine and surgery (2012)2026
Perioperative camrelizumab plus rivoceranib in resectable hepatocellular carcinoma: translating CARES-009 outcomes into a new therapeutic paradigm.
Asra Amjad et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.